|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Service | |||
| Product | |||
| Total revenue | |||
| OPERATING EXPENSES: | |||
| Cost of services and product sales exclusive of depreciation expense shown below | |||
| Service | |||
| Product | |||
| General and administrative expense, exclusive of depreciation expense shown below | |||
| Depreciation | |||
| Amortization | |||
| Other (income) expense, net | |||
| OPERATING INCOME | |||
| Interest expense | |||
| Income before income taxes | |||
| Income tax expense | |||
| Net income | |||
| Net income attributable to non-controlling interest | |||
| Net income attributable to Core Laboratories Inc. | |||
| EARNINGS PER SHARE INFORMATION: | |||
| Basic earnings per share | |||
| Basic earnings per share attributable to Core Laboratories Inc. | |||
| Diluted earnings per share | |||
| Diluted earnings per share attributable to Core Laboratories Inc. | |||
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | |||
| Basic | |||
| Diluted |
Loading...